Certara Inc.

22.54+0.3700+1.67%Vol 997.79K1Y Perf -17.95%
Jun 24th, 2022 16:00 DELAYED
BID21.79 ASK23.08
Open22.52 Previous Close22.17
Pre-Market- After-Market22.54
 - -  - -%
Target Price
26.25 
Analyst Rating
Strong Buy 1.40
Potential %
16.46 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★+     53.08
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★     50.51
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
21.72 
Earnings Rating
Market Cap3.60B 
Earnings Date
4th Aug 2022
Alpha-0.03 Standard Deviation0.16
Beta1.53 

Today's Price Range

22.3023.11

52W Range

16.1845.48

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
23.37%
1 Month
16.97%
3 Months
5.33%
6 Months
-23.26%
1 Year
-17.95%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
CERT22.540.37001.67
AAPL141.663.39002.45
GOOG2 370.76117.07005.19
MSFT267.708.84003.41
XOM86.901.69001.98
WFC40.762.86007.55
JNJ182.292.63001.46
FB196.640.99000.51
GE67.083.01004.70
JPM117.323.40002.98
Earnings HistoryEstimateReportedSurprise %
Q01 20220.110.110.00
Q04 20210.090.01-88.89
Q03 20210.060.0716.67
Q02 20210.050.03-40.00
Q01 20210.040.0650.00
Q04 2020-0.42-0.3711.90
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date4th Aug 2022
Estimated EPS Next Report0.11
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume997.79K
Shares Outstanding159.84K
Shares Float116.25M
Trades Count11.92K
Dollar Volume22.60M
Avg. Volume542.68K
Avg. Weekly Volume571.45K
Avg. Monthly Volume538.16K
Avg. Quarterly Volume518.43K

Certara Inc. (NASDAQ: CERT) stock closed at 22.54 per share at the end of the most recent trading day (a 1.67% change compared to the prior day closing price) with a volume of 997.79K shares and market capitalization of 3.60B. Is a component of Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 899 people. Certara Inc. CEO is William F. Feehery.

The one-year performance of Certara Inc. stock is -17.95%, while year-to-date (YTD) performance is -20.69%. CERT stock has a five-year performance of %. Its 52-week range is between 16.175 and 45.48, which gives CERT stock a 52-week price range ratio of 21.72%

Certara Inc. currently has a PE ratio of -203.00, a price-to-book (PB) ratio of 2.79, a price-to-sale (PS) ratio of 9.70, a price to cashflow ratio of 42.60, a PEG ratio of 2.32, a ROA of -0.90%, a ROC of -0.20% and a ROE of -1.32%. The company’s profit margin is -3.95%, its EBITDA margin is 20.70%, and its revenue ttm is $300.94 Million , which makes it $1.88 revenue per share.

Of the last four earnings reports from Certara Inc., there were 1 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $0.11 for the next earnings report. Certara Inc.’s next earnings report date is 04th Aug 2022.

The consensus rating of Wall Street analysts for Certara Inc. is Strong Buy (1.4), with a target price of $26.25, which is +16.46% compared to the current price. The earnings rating for Certara Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Certara Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Certara Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 14.75, ATR14 : 1.23, CCI20 : 238.98, Chaikin Money Flow : -0.02, MACD : 0.33, Money Flow Index : 73.50, ROC : 16.55, RSI : 66.68, STOCH (14,3) : 91.00, STOCH RSI : 1.00, UO : 63.49, Williams %R : -9.00), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Certara Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (80.00 %)
4 (80.00 %)
4 (80.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (20.00 %)
1 (20.00 %)
1 (20.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.40
Strong Buy
1.40
Strong Buy
1.40

Certara Inc.

Certara Inc accelerate medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides proven modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trial, accelerate regulatory approval and increase patient access to medicines.

CEO: William F. Feehery

Telephone: +1 609 716-7900

Address: 100 Overlook Center, Princeton 08540, NJ, US

Number of employees: 899

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

59%41%

Bearish Bullish

59%41%

Bearish Bullish

60%40%

News

Stocktwits